Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check7 days agoChange DetectedGastric cancer added as a condition for the study. Resources section now includes a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision: v3.4.2 is displayed. The prior government-funding operating-status notice has been removed; core study details remain unchanged.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding/status notice was added and the site version updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page updates add a Show glossary option, adjust labeling for QC status, and update footer/version text related to No FEAR Act and revisions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedThe revision label on the page was updated from v3.3.3 to v3.3.4. No substantive content or functionality changes were observed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section listing California, Oklahoma, and Wisconsin; removed the HHS Vulnerability Disclosure link; updated revision to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.